Inhibikase Therapeutics, Inc. (IKT) SEC Filings https://www.inhibikase.com/investors/sec-filings/all-sec-filings/rss Inhibikase Therapeutics, Inc. (IKT) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/inhibikase/files/theme/images/logo-sm.png Inhibikase Therapeutics, Inc. Logo /investors Equisolve Investor Relations Suite <![CDATA[PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-163935/0001193125-26-163935.pdf Mon, 20 Apr 26 16:06:24 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-163935/0001193125-26-163935.pdf <![CDATA[8-K - Current report]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-144582/0001193125-26-144582.pdf Tue, 07 Apr 26 08:09:37 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-144582/0001193125-26-144582.pdf <![CDATA[S-8 - Securities to be offered to employees in employee benefit plans]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-126573/0001193125-26-126573.pdf Thu, 26 Mar 26 17:10:23 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-126573/0001193125-26-126573.pdf <![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-126371/0001193125-26-126371.pdf Thu, 26 Mar 26 16:33:25 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-126371/0001193125-26-126371.pdf <![CDATA[8-K - Current report]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-126322/0001193125-26-126322.pdf Thu, 26 Mar 26 16:23:36 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-126322/0001193125-26-126322.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-068079/0001193125-26-068079.pdf Tue, 24 Feb 26 20:54:53 -0500 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-068079/0001193125-26-068079.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-068077/0001193125-26-068077.pdf Tue, 24 Feb 26 20:54:08 -0500 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-068077/0001193125-26-068077.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-068063/0001193125-26-068063.pdf Tue, 24 Feb 26 20:49:21 -0500 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-068063/0001193125-26-068063.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001104659-26-016623/0001104659-26-016623.pdf Tue, 14 Apr 26 13:10:18 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001104659-26-016623/0001104659-26-016623.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001104659-26-016478/0001104659-26-016478.pdf Tue, 14 Apr 26 13:10:16 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001104659-26-016478/0001104659-26-016478.pdf